Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $1.80 billion. The enterprise value is $1.33 billion.

Market Cap	1.80B
Enterprise Value	1.33B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025, before market open.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 29.76 million shares outstanding. The number of shares has increased by 58.56% in one year.

Current Share Class	29.76M
Shares Outstanding	29.76M
Shares Change (YoY)	+58.56%
Shares Change (QoQ)	+16.71%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	62.27%
Float	16.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.70
P/TBV Ratio	3.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.36, with a Debt / Equity ratio of 0.00.

Current Ratio	19.36
Quick Ratio	19.13
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.03% and return on invested capital (ROIC) is -18.79%.

Return on Equity (ROE)	-25.03%
Return on Assets (ROA)	-17.91%
Return on Capital (ROIC)	-18.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $211,000 in taxes.

Income Tax	211,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.89% in the last 52 weeks. The beta is 2.94, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.94
52-Week Price Change	-5.89%
50-Day Moving Average	63.02
200-Day Moving Average	47.39
Relative Strength Index (RSI)	48.31
Average Volume (20 Days)	263,382

Short Selling Information

The latest short interest is 1.77 million, so 5.95% of the outstanding shares have been sold short.

Short Interest	1.77M
Short Previous Month	1.66M
Short % of Shares Out	5.95%
Short % of Float	10.67%
Short Ratio (days to cover)	7.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-124.88M
Pretax Income	-90.89M
Net Income	-103.48M
EBITDA	-124.71M
EBIT	-124.88M
Earnings Per Share (EPS)	-$3.95

Full Income Statement

Balance Sheet

The company has $487.36 million in cash and $1.79 million in debt, giving a net cash position of $485.58 million or $16.32 per share.

Cash & Cash Equivalents	487.36M
Total Debt	1.79M
Net Cash	485.58M
Net Cash Per Share	$16.32
Equity (Book Value)	467.96M
Book Value Per Share	15.73
Working Capital	467.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$84.15 million and capital expenditures -$59,000, giving a free cash flow of -$84.21 million.

Operating Cash Flow	-84.15M
Capital Expenditures	-59,000
Free Cash Flow	-84.21M
FCF Per Share	-$2.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.56%
Shareholder Yield	-58.56%
Earnings Yield	-5.71%
FCF Yield	-4.65%

Dividend Details

Analyst Forecast

The average price target for Disc Medicine is $73.70, which is 21.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.70
Price Target Difference	21.78%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1